Latest filing published 10 Aug 2023 for Mirati Therapeutics, Inc., €752k.
Laurie Stelzer is a declared insider at 3 companies (finance chief); the most frequent names are Halozyme Therapeutics, Inc., Mirati Therapeutics, Inc. and Arena Pharmaceuticals Inc. In total, 22 filings cover trades dated from 3 February 2019 to 9 August 2023.
The open-market record consists of 1 sale worth €160k, with no purchase. Other entries cover 12 share grants and 8 option exercises. Since January 2023: no purchases and 1 sale on the market.
The newest entry dates from 10 August 2023: a share grant of €752k, in Mirati Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations